{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:27:42Z","timestamp":1789993662051,"version":"4.0.1"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2017,10,25]],"date-time":"2017-10-25T00:00:00Z","timestamp":1508889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007225","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["2016YFC1306802"],"award-info":[{"award-number":["2016YFC1306802"]}],"id":[{"id":"10.13039\/100007225","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007225","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["2016YFC1306900"],"award-info":[{"award-number":["2016YFC1306900"]}],"id":[{"id":"10.13039\/100007225","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["13dz2260500"],"award-info":[{"award-number":["13dz2260500"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6,6]]},"DOI":"10.1093\/schbul\/sbx150","type":"journal-article","created":{"date-parts":[[2017,9,28]],"date-time":"2017-09-28T11:10:31Z","timestamp":1506597031000},"page":"896-907","source":"Crossref","is-referenced-by-count":44,"title":["Identification of the Niacin-Blunted Subgroup of Schizophrenia Patients from Mood Disorders and Healthy Individuals in Chinese Population"],"prefix":"10.1093","volume":"44","author":[{"given":"Liya","family":"Sun","sequence":"first","affiliation":[{"name":"Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China"},{"name":"Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Centre, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"Shanghai Center for Women and Children's Health, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuhan","family":"Yang","sequence":"additional","affiliation":[{"name":"Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China"},{"name":"Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Centre, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Jiang","sequence":"additional","affiliation":[{"name":"Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China"},{"name":"Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Centre, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Hu","sequence":"additional","affiliation":[{"name":"Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China"},{"name":"Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Centre, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Qing","sequence":"additional","affiliation":[{"name":"Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China"},{"name":"Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Centre, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Wang","sequence":"additional","affiliation":[{"name":"Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China"},{"name":"Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Centre, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianqi","family":"Yang","sequence":"additional","affiliation":[{"name":"Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China"},{"name":"Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Centre, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Yang","sequence":"additional","affiliation":[{"name":"Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China"},{"name":"Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Centre, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Yang","sequence":"additional","affiliation":[{"name":"The Fourth People\u2019s Hospital of Wuhu, Wuhu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[{"name":"The Fourth People\u2019s Hospital of Wuhu, Wuhu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changqun","family":"Cai","sequence":"additional","affiliation":[{"name":"The Fourth People\u2019s Hospital of Wuhu, Wuhu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jijun","family":"Wang","sequence":"additional","affiliation":[{"name":"Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Centre, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"He","sequence":"additional","affiliation":[{"name":"Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunling","family":"Wan","sequence":"additional","affiliation":[{"name":"Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China"},{"name":"Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Centre, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,10,25]]},"reference":[{"key":"key\n\t\t\t\t20180606045742_CIT0001","first-page":"54","article-title":"Schizophrenia: a biochemical disorder","volume":"32","author":"Horrobin","year":"1980","journal-title":"Biomedicine"},{"key":"key\n\t\t\t\t20180606045742_CIT0002","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/0006-3223(91)90202-W","article-title":"Niacin test in schizophrenia and affective illness","volume":"29","author":"Rybakowski","year":"1991","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t20180606045742_CIT0003","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0920-9964(97)00100-X","article-title":"Niacin skin flush in schizophrenia: a preliminary report","volume":"29","author":"Ward","year":"1998","journal-title":"Schizophr Res"},{"key":"key\n\t\t\t\t20180606045742_CIT0004","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0920-9964(02)00311-0","article-title":"The niacin skin flush abnormality in schizophrenia: a quantitative dose-response study","volume":"62","author":"Messamore","year":"2003","journal-title":"Schizophr Res"},{"key":"key\n\t\t\t\t20180606045742_CIT0005","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jpsychires.2004.01.007","article-title":"The influence of age and gender on niacin skin test results\u2014implications for the use as a biochemical marker in schizophrenia","volume":"38","author":"Smesny","year":"2004","journal-title":"J Psychiatr Res"},{"key":"key\n\t\t\t\t20180606045742_CIT0006","first-page":"14","article-title":"Niacin skin flush test: a research tool for studying schizophrenia","volume":"22","author":"Nadalin","year":"2010","journal-title":"Psychiatr Danub"},{"key":"key\n\t\t\t\t20180606045742_CIT0007","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.psychres.2006.10.002","article-title":"Absent response to niacin skin patch is specific to schizophrenia and independent of smoking","volume":"152","author":"Liu","year":"2007","journal-title":"Psychiatry Res"},{"key":"key\n\t\t\t\t20180606045742_CIT0008","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1093\/schbul\/sbl038","article-title":"Familial aggregation in skin flush response to niacin patch among schizophrenic patients and their nonpsychotic relatives","volume":"33","author":"Lin","year":"2007","journal-title":"Schizophr Bull"},{"key":"key\n\t\t\t\t20180606045742_CIT0009","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.encep.2008.03.011","article-title":"How to differentiate schizophrenia from bipolar disorder using cognitive assessment","volume":"35","author":"Demily","year":"2009","journal-title":"Encephale"},{"key":"key\n\t\t\t\t20180606045742_CIT0010","doi-asserted-by":"crossref","first-page":"e389","DOI":"10.1038\/tp.2014.26","article-title":"Decreased BDNF and TrkB mRNA expression in multiple cortical areas of patients with schizophrenia and mood disorders","volume":"4","author":"Ray","year":"2014","journal-title":"Transl Psychiatry"},{"key":"key\n\t\t\t\t20180606045742_CIT0011","first-page":"1","article-title":"The schizophrenia susceptibility gene ZNF804A confers risk of major mood disorders","author":"Ou","year":"2016;18","journal-title":"World J Biol Psychiatry"},{"key":"key\n\t\t\t\t20180606045742_CIT0012","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/sj.mp.4001223","article-title":"Differences in neuroanatomical sites of apoD elevation discriminate between schizophrenia and bipolar disorder","volume":"8","author":"Thomas","year":"2003","journal-title":"Mol Psychiatry"},{"key":"key\n\t\t\t\t20180606045742_CIT0013","first-page":"313","article-title":"Symptom clusters in the diagnosis of affective disorder, schizoaffective disorder, and schizophrenia in African Americans","volume":"94","author":"Whaley","year":"2002","journal-title":"J Natl Med Assoc"},{"key":"key\n\t\t\t\t20180606045742_CIT0014","first-page":"241","article-title":"Overlap between schizophrenia and affective disorders\u2014a family study","volume":"126","author":"Knobler","year":"1994","journal-title":"Harefuah"},{"key":"key\n\t\t\t\t20180606045742_CIT0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/09540260500064959","article-title":"Mood disorder with psychotic features, schizoaffective disorder, and schizophrenia with mood features: trouble at the borders","volume":"17","author":"Kempf","year":"2005","journal-title":"Int Rev Psychiatry"},{"key":"key\n\t\t\t\t20180606045742_CIT0016","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0006-3223(96)00112-6","article-title":"The niacin challenge test: clinical manifestation of altered transmembrane signal transduction in schizophrenia","volume":"41","author":"Hudson","year":"1997","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t20180606045742_CIT0017","doi-asserted-by":"crossref","DOI":"10.1016\/S0278-5846(03)00152-0","article-title":"On the relationship between methylnicotinate-induced skin flush and fatty acids levels in acute psychosis","author":"Maclean","year":"2003;27:927\u2013933","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"key\n\t\t\t\t20180606045742_CIT0018","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/schbul\/sbv130","article-title":"Prevalence and specificity of the abnormal niacin response: a potential endophenotype marker in schizophrenia","volume":"42","author":"Yao","year":"2016","journal-title":"Schizophr Bull"},{"key":"key\n\t\t\t\t20180606045742_CIT0019","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.psychres.2005.10.010","article-title":"Niacin skin flushing in schizophrenic and depressed patients and healthy controls","volume":"143","author":"Bosveld-van Haandel","year":"2006","journal-title":"Psychiatry Res"},{"key":"key\n\t\t\t\t20180606045742_CIT0020","doi-asserted-by":"crossref","first-page":"e0148429","DOI":"10.1371\/journal.pone.0148429","article-title":"Niacin skin sensitivity is increased in adolescents at ultra-high risk for psychosis","volume":"11","author":"Berger","year":"2016","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180606045742_CIT0021","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0022-3956(03)00006-2","article-title":"Potential use of the topical niacin skin test in early psychosis\u2014a combined approach using optical reflection spectroscopy and a descriptive rating scale","volume":"37","author":"Smesny","year":"2003","journal-title":"J Psychiatr Res"},{"key":"key\n\t\t\t\t20180606045742_CIT0022","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0278-5846(01)00220-2","article-title":"A volumetric biochemical niacin flush-based index that noninvasively detects fatty acid deficiency in schizophrenia","volume":"26","author":"Puri","year":"2002","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"key\n\t\t\t\t20180606045742_CIT0023","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.plefa.2012.11.005","article-title":"The impact of PLA2G4A and PTGS2 gene polymorphisms, and red blood cell PUFAs deficit on niacin skin flush response in schizophrenia patients","volume":"88","author":"Nadalin","year":"2013","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"key\n\t\t\t\t20180606045742_CIT0024","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1017\/S0033291700003147","article-title":"Age of onset in bipolar affective disorder and misdiagnosis as schizophrenia","volume":"14","author":"Joyce","year":"1984","journal-title":"Psychol Med"},{"key":"key\n\t\t\t\t20180606045742_CIT0025","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jad.2003.11.005","article-title":"Delayed vasodilatory response to methylnicotinate in patients with unipolar depressive disorder","volume":"82","author":"Ross","year":"2004","journal-title":"J Affect Disord"},{"key":"key\n\t\t\t\t20180606045742_CIT0026","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.schres.2012.03.001","article-title":"Niacin subsensitivity is associated with functional impairment in schizophrenia","volume":"137","author":"Messamore","year":"2012","journal-title":"Schizophr Res"},{"key":"key\n\t\t\t\t20180606045742_CIT0027","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0952-3278(96)90139-8","article-title":"Membrane fatty acids, niacin flushing and clinical parameters","volume":"55","author":"Glen","year":"1996","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"key\n\t\t\t\t20180606045742_CIT0028","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1742-1241.2001.tb11065.x","article-title":"The niacin skin flush test in schizophrenia: a replication study","volume":"55","author":"Puri","year":"2001","journal-title":"Int J Clin Pract"},{"key":"key\n\t\t\t\t20180606045742_CIT0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(02)00281-5","article-title":"Increased phospholipase A2 activity in schizophrenia with absent response to niacin","volume":"61","author":"Tavares","year":"2003","journal-title":"Schizophr Res"},{"key":"key\n\t\t\t\t20180606045742_CIT0030","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0006-3223(99)00010-4","article-title":"Clinical subtyping reveals significant differences in calcium-dependent phospholipase A2 activity in schizophrenia","volume":"46","author":"Hudson","year":"1999","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t20180606045742_CIT0031","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0924-977X(03)00145-7","article-title":"Reduced vasodilatory response to methylnicotinate in schizophrenia as assessed by laser Doppler flowmetry","volume":"14","author":"Ross","year":"2004","journal-title":"Eur Neuropsychopharmacol"},{"key":"key\n\t\t\t\t20180606045742_CIT0032","first-page":"163","article-title":"Unmedicated schizophrenic patients have a reduced skin flush in response to topical niacin","volume":"43","author":"Shah","year":"2000","journal-title":"Schizophr Res"},{"key":"key\n\t\t\t\t20180606045742_CIT0033","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1515\/bmte.2001.46.10.280","article-title":"Quantitative measurement of induced skin reddening using optical reflection spectroscopy\u2014methodology and clinical application","volume":"46","author":"Smesny","year":"2001","journal-title":"Biomed Tech (Berl)"},{"key":"key\n\t\t\t\t20180606045742_CIT0034","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1055\/s-2001-18689","article-title":"Gender differences in the vasomotor effects of different steroid hormones in rat pulmonary and coronary arteries","volume":"33","author":"English","year":"2001","journal-title":"Horm Metab Res"},{"key":"key\n\t\t\t\t20180606045742_CIT0035","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ajmg.b.20156","article-title":"Association of a long-chain fatty acid-CoA ligase 4 gene polymorphism with depression and with enhanced niacin-induced dermal erythema","volume":"127B","author":"Covault","year":"2004","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"key\n\t\t\t\t20180606045742_CIT0036","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.plefa.2005.02.007","article-title":"Impaired niacin sensitivity in acute first-episode but not in multi-episode schizophrenia","volume":"72","author":"Smesny","year":"2005","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"key\n\t\t\t\t20180606045742_CIT0037","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0006-3223(99)00092-X","article-title":"Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia","volume":"47","author":"Fenton","year":"2000","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t20180606045742_CIT0038","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.plefa.2003.08.013","article-title":"Relationship between the niacin skin flush response and essential fatty acids in schizophrenia","volume":"69","author":"Messamore","year":"2003","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"key\n\t\t\t\t20180606045742_CIT0039","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.schres.2010.03.025","article-title":"Niacin sensitivity and the arachidonic acid pathway in schizophrenia","volume":"122","author":"Messamore","year":"2010","journal-title":"Schizophr Res"},{"key":"key\n\t\t\t\t20180606045742_CIT0040","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0006-3223(02)01397-5","article-title":"Correlations between peripheral polyunsaturated fatty acid content and in vivo membrane phospholipid metabolites","volume":"52","author":"Yao","year":"2002","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t20180606045742_CIT0041","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF02191810","article-title":"Intracerebral injection of phospholipase A2 inhibits dopamine-mediated behavior in rats: possible implications for schizophrenia","volume":"246","author":"Brunner","year":"1995","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"key\n\t\t\t\t20180606045742_CIT0042","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.2174\/156802612805289845","article-title":"Alterations of brain membranes in schizophrenia: impact of phospholipase A(2)","volume":"12","author":"Schaeffer","year":"2012","journal-title":"Curr Top Med Chem"},{"key":"key\n\t\t\t\t20180606045742_CIT0043","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0920-9964(96)00031-X","article-title":"Genetic variant near cytosolic phospholipase A2 associated with schizophrenia","volume":"21","author":"Hudson","year":"1996","journal-title":"Schizophr Res"},{"key":"key\n\t\t\t\t20180606045742_CIT0044","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1001\/archpsyc.1997.01830170113015","article-title":"Increased phospholipid breakdown in schizophrenia. Evidence for the involvement of a calcium-independent phospholipase A2","volume":"54","author":"Ross","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"key\n\t\t\t\t20180606045742_CIT0045","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/09540260600583072","article-title":"Bioactive lipids in schizophrenia","volume":"18","author":"Berger","year":"2006","journal-title":"Int Rev Psychiatry"},{"key":"key\n\t\t\t\t20180606045742_CIT0046","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.schres.2015.06.022","article-title":"Implications for reactive oxygen species in schizophrenia pathogenesis","volume":"176","author":"Koga","year":"2016","journal-title":"Schizophr Res"},{"key":"key\n\t\t\t\t20180606045742_CIT0047","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/mp.2011.131","article-title":"Potential metabolite markers of schizophrenia","volume":"18","author":"Yang","year":"2013","journal-title":"Mol Psychiatry"},{"key":"key\n\t\t\t\t20180606045742_CIT0048","doi-asserted-by":"crossref","first-page":"e1176","DOI":"10.1038\/tp.2017.152","article-title":"Serum fatty acid patterns in patients with schizophrenia: a targeted metabonomics study","volume":"7","author":"Yang","year":"2017","journal-title":"Transl Psychiatry"},{"key":"key\n\t\t\t\t20180606045742_CIT0049","volume-title":"Phospholipid Spectrum Disorders in Psychiatry and Neurology","author":"Peet","year":"2003","edition":"2nd ed"},{"key":"key\n\t\t\t\t20180606045742_CIT0050","first-page":"988","article-title":"Niacin-respondent subset of schizophrenia\u2014a therapeutic review","volume":"19","author":"Xu","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"}],"container-title":["Schizophrenia Bulletin"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/schizophreniabulletin\/article-pdf\/44\/4\/896\/24973661\/sbx150.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T13:10:48Z","timestamp":1693055448000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/schizophreniabulletin\/article\/44\/4\/896\/4564459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,25]]},"references-count":50,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,10,25]]},"published-print":{"date-parts":[[2018,6,6]]}},"URL":"https:\/\/doi.org\/10.1093\/schbul\/sbx150","relation":{},"ISSN":["0586-7614","1745-1701"],"issn-type":[{"value":"0586-7614","type":"print"},{"value":"1745-1701","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,7]]},"published":{"date-parts":[[2017,10,25]]}}}